Nexodyn®
AcidOxidizing Solution (AOS), the Tehclo-based Wound Cleanser, is a sprayable solution with an ancillary
antimicrobial activity developed for acute and chronic wound management.
A wide array of
non-clinical experiments and clinical experiences and studies suggest Nexodyn®
AcidOxidizing Solution (AOS) to perform as a Wound Rebooter by creating the
ideal microenvironment to sustain the physiological healing process.
Rebooting
a wound, favoring an optimized lesion closure and ensuring a favorable safety
and tolerability profile, is especially relevant with chronic wounds.
Developed based on
APR’s proprietary and patented technology TEHCLO®, the product is a newly
conceived solution with three main features: highly pure and stabilized hypochlorous
acid (HClO >95% of free chlorine species), acidic pH (2.5 – 3.0) and high
Reduction-Oxidation Potential (ORP >1.000 mV).
Nexodyn®
AcidOxidizing Solution (AOS) is intended for use in the debridement,
irrigation, cleansing and moistening of acute and chronic wounds (e.g. diabetic
foot ulcers, pressure ulcers, vascular ulcers), post-surgical wounds, burns and
other lesions.
As observed in
non-clinical experiments and clinical experiences, Nexodyn® AcidOxidizing
Solution (AOS) has synergic physico-chemical properties sustaining wound
rebooting to the benefit of patients and HCPs who can rely on the reactivation
of the physiological healing process concomitantly to protection and management
of uncontrolled microbial growth.
Nexodyn® AcidOxidizing Solution (AOS) shows favorable tolerability, with
no pain exacerbation, for prolonged periods of use and across the wound healing
continuum.